Star Combo Pharma Limited (ASX:S66)

Star Combo Pharma Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 3, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	28	18	15	15	21	34
Market Cap Growth	115.79%	22.73%	-	-28.77%	-39.31%	-36.64%
Enterprise Value	14	9	10	10	10	18
Last Close Price	0.20	0.13	0.11	0.11	0.15	0.25
PE Ratio	6.71	4.58	19.88	-	-	-
PS Ratio	1.15	0.66	0.57	0.60	0.91	1.27
PB Ratio	0.72	0.48	0.44	0.45	0.59	0.95
P/TBV Ratio	0.73	0.49	0.46	0.46	0.60	1.02
P/FCF Ratio	4.58	1.58	-	-	-	-
P/OCF Ratio	4.22	1.53	-	7.92	39.07	103.68
EV/Sales Ratio	0.58	0.34	0.38	0.42	0.45	0.65
EV/EBITDA Ratio	1.96	1.42	5.76	6.40	28.43	-
EV/EBIT Ratio	2.78	1.88	10.80	9.28	-	-
EV/FCF Ratio	2.31	0.82	-	-	-	-
Debt / Equity Ratio	0.11	0.10	0.12	0.13	0.12	0.09
Debt / EBITDA Ratio	0.60	0.57	2.03	2.57	6.96	-
Debt / FCF Ratio	0.71	0.34	-	-	-	-
Net Debt / Equity Ratio	-0.36	-0.37	-0.10	-0.16	-0.18	-0.39
Net Debt / EBITDA Ratio	-2.02	-2.14	-1.92	-3.25	-17.13	9.13
Net Debt / FCF Ratio	-2.30	-1.23	1.89	6.24	0.93	2.03
Asset Turnover	0.53	0.61	0.61	0.58	0.53	0.55
Inventory Turnover	4.44	3.81	3.85	4.16	3.81	4.76
Quick Ratio	5.57	3.50	2.43	3.13	3.28	5.61
Current Ratio	6.64	4.40	3.77	4.18	4.76	7.45
Return on Equity (ROE)	14.86%	14.63%	2.24%	-11.66%	-1.94%	-19.52%
Return on Assets (ROA)	6.96%	6.85%	1.36%	1.64%	-0.09%	-2.53%
Return on Invested Capital (ROIC)	20.01%	18.21%	2.37%	3.93%	-0.25%	-8.67%
Return on Capital Employed (ROCE)	11.60%	11.70%	2.40%	3.00%	-0.20%	-5.00%
Earnings Yield	14.87%	28.78%	5.03%	-26.94%	-3.34%	-22.91%
FCF Yield	21.81%	63.32%	-11.83%	-5.71%	-32.41%	-20.15%
Dividend Yield	1.76%	2.79%	3.50%	-	-	-
Payout Ratio	9.28%	9.53%	-	-	-	-
Buyback Yield / Dilution	2.39%	-	-	-0.37%	0.15%	-47.45%
Total Shareholder Return	4.24%	2.79%	3.50%	-0.37%	0.15%	-47.45%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.